OWC Pharmaceutical Research Corp (OWCP)

[AlexSwiss]

MM Safety also schedule in 2018, from last 8K:

« 
In December 2017, OWC Pharmaceutical Research Corp received a new permit from the Israel Medical Cannabis Agency [MCA] to proceed with the safety study of their oral disintegrating tablet. The study protocol will be submitted to the Institutional Review Board [IRB] at a leading Israeli academic hospital in the coming weeks. The study is scheduled to start in Q2 2018.
In October of 2016 OWC announced that it had completed the development of a proprietary cannabinoid-enriched sublingual tablet (the “Tablet”) for the administration of medical cannabis. The Tablet constitutes a smoke-free alternative for patients using medical cannabis. »